All In Biotech

Drug Trial Radar · NCT07161544

A Study of AAVB-039 in Participants With Stargardt Disease (STGD1)

An Open-label, Multicenter, Two Part, Ascending Dose Followed by a Controlled Trial to Assess the Safety and Efficacy of a Subretinal Administration of AAVB-039 in Participants With Stargardt Disease (STGD1) (CELESTE)

Last checked: Nov 19, 2026Latest source record: Sep 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

75

Planned (sponsor's estimate)

Start

Sep 29, 2025

Primary completion

Jul 2032

Study completion Jul 2032

Sponsor

Lead sponsor
AAVantgarde Bio SrlIndustry
Sponsor type
Industry
Collaborators
AAVantgarde Bio UK Ltd
First posted
Sep 8, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 8 years, up to 55 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the 039-101 study is to evaluate the safety and tolerability of a single subretinal injection of AAVB-039 in participants with Stargardt disease secondary to a biallelic mutation of the ABCA4 gene. The study will also assess initial efficacy following AAVB-039 administration.

Conditions

  • Stargardt Disease

Interventions

  • AAVB-039Biological

    Single subretinal administration

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To measure the number and severity of treatment related adverse events following treatment with AAVB-039Time frame: 0-60 months

Locations

11 sites in 3 countries. Site status is shown where the registry gives one.

  • Associated Retina Consultants

    Phoenix, Arizona · Recruiting

  • Children's Hospital Los Angeles

    Los Angeles, California · Recruiting

  • Retina Vitreous Associates Medical Group

    Los Angeles, California · Recruiting

  • University of Florida Health Science Center

    Jacksonville, Florida · Recruiting

  • Mayo Clinic

    Rochester, Minnesota · Recruiting

  • Retina Consultants of Texas

    Bellaire, Texas · Recruiting

  • Retina Foundation of the Southwest

    Dallas, Texas · Recruiting

  • University of Utah

    Salt Lake City, Utah · Recruiting

  • Oslo University Hospital

    Oslo, Kirkeveien 166, Norway · Recruiting

  • Moorfields Eye Hospital NHS Foundation Trust

    London, England, United Kingdom · Recruiting

  • The Retina Clinic

    London, England, United Kingdom · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.